Ben venue fallout continues to cause headache for Boehringer Ingelheim

Divested sterile manufacturer Ben Venue has continued to cause trouble for Boehringer Ingelheim with a second recall this year of an injectable drug made at the now defunct site.

http://www.in-pharmatechnologist.com/Regulatory-Safety/Ben-venue-fallout-continues-to-cause-headache-for-Boehringer-Ingelheim